Research programme: TRAIL receptor agonists - MedimmuneAlternative Names: MEDI 3039
Latest Information Update: 07 May 2016
At a glance
- Originator MedImmune
- Class Antineoplastics
- Mechanism of Action TNF-related apoptosis-inducing ligand receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Breast cancer